Anti-Human ABL1 Antibody with collaborator-tested evidence for IHC.
Know who made it. See the evidence. Buy through one marketplace.
Anti-Human ABL1 Antibody is a research-use antibody from Elabscience for studying ABL1 in IHC workflows with listed reactivity for Human. Specifications and supporting documents below should be reviewed when planning the experiment.
Fully tested in-house by ABMIUM. Highest confidence. Non-conformities fully supported under the ABMIUM Product Promise.
Quality verified. Independent collaborator or expected-performance data available. Product meets ABMIUM quality standards.
Expected to work based on structural and biochemical data. Not yet directly tested by ABMIUM or a collaborator. No non-conformity support for this combination.
Not recommended for this application or species/sample combination. This may indicate either evidence of unsuitability or that the combination has not been tested and therefore cannot currently be recommended.
Evidence status by application and model.
| Species | WB | IHC-P | IHC-Fr | IF/ICC | Flow Cyt | IP | ChIP | IHC |
|---|---|---|---|---|---|---|---|---|
| Human |
This product is manufactured by Elabscience and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
ABL1 is ABL proto-oncogene 1, non-receptor tyrosine kinase, encoding the c-Abl/tyrosine-protein kinase ABL1 protein. This record links the verified human identity (NCBI Gene 25; UniProt P00519) to ABMIUM catalogue products.
Biological function: ABL1 encodes tyrosine-protein kinase ABL1 (c-Abl), a non-receptor tyrosine kinase involved in cell division, adhesion, differentiation and cellular stress responses. ABL1 is also a recurrent fusion partner in cancer biology, most notably in the BCR::ABL1 fusion context.
